Longevity Optimization: What It Is, What the Evidence Says, and Where to Start
By John Stewart, SVP Growth & Performance Optimization · Last reviewed: August 2026
Longevity optimization has become a marketing category. Underneath the plasma exchanges and the supplement stacks sits a much smaller set of interventions that actually hold up, and a short list of numbers that tell you whether they are working. This page separates the two.
Lifespan and healthspan are not the same target
Most longevity content conflates two different goals. Lifespan is how many years you live. Healthspan is how many of those years you spend without chronic disease or meaningful functional decline. In most developed countries the gap between the two runs close to a decade — years lived with disease, medication, and progressively narrowing capability.
That distinction changes what you optimize for. Extending lifespan alone can simply lengthen the decline. Extending healthspan means compressing it: staying strong, aerobically capable, metabolically clean, and cognitively sharp for as long as possible, then declining quickly rather than slowly. Every intervention below should be judged against that second target, because it is the one you actually experience.
There is a practical benefit to this framing. Healthspan interventions pay out now. Higher VO2 max means you are less tired at week's end. More muscle means you carry luggage and children without thinking about it. Better metabolic health means stable energy through the afternoon. You do not have to wait thirty years to know whether the work is landing.
The four interventions with real evidence
These four account for the overwhelming majority of the modifiable risk you control. Nothing on the speculative list comes close to their evidence base in humans.
VO2 max
Cardiorespiratory fitness is the single strongest modifiable predictor of all-cause mortality in the observational literature, and the dose-response does not plateau: moving from the bottom quartile to above average is associated with a larger risk reduction than eliminating smoking, hypertension, or type 2 diabetes. The practical protocol is unglamorous — three to four hours weekly of low-intensity zone 2 work plus one weekly session of four-minute intervals near maximum effort.
Resistance training
Muscle mass and grip strength both track independently with mortality and, more importantly, with the ability to remain independent after seventy. Sarcopenia begins in the fourth decade and accelerates; the only reliable countermeasure is progressive loading two to four times a week with sufficient protein. Strength built in your forties is the reserve you spend in your eighties.
Sleep
Chronic short sleep degrades glucose control within days, raises evening cortisol, suppresses testosterone, and is associated with increased cardiovascular and neurodegenerative risk. Seven to nine hours is not a preference. It is the window in which most of the recovery you attribute to training actually happens.
Metabolic health
Insulin resistance sits upstream of most chronic disease — cardiovascular, oncologic, and neurodegenerative. Fasting insulin usually rises years before fasting glucose does, which is why a normal glucose result is a weak reassurance. Keeping insulin, HbA1c and ApoB in range through body composition, training and diet quality is the highest-leverage metabolic work available.
The exciting but unproven
The compounds below are genuinely interesting and are being studied seriously. None of them has human evidence that justifies displacing the four interventions above, and in practice they are usually adopted by people who have not yet done the basic work. Mechanism is not outcome.
Rapamycin
Robust lifespan extension in mice; no completed human longevity trial. Off-label use is a bet on translation, with real immunosuppression and glucose-tolerance tradeoffs.
Senolytics
Compelling mechanism — clearing senescent cells — but human data are limited to small, short trials in specific diseases. Dosing schedules in healthy adults are guesswork.
NMN / NR (NAD precursors)
Reliably raise blood NAD+ levels. Human trials have not shown that raising NAD+ produces meaningful changes in function, body composition, or disease risk.
Medical disclaimer. This page is educational and is not medical advice. Prescription compounds discussed here require a licensed physician who has reviewed your labs and history.
The five biomarkers to start with
If you have never tested, do not order a hundred-marker panel. Order these five, understand them, and act on them. They cover atherosclerosis, insulin resistance, inflammation, and fitness — the four processes that decide most outcomes.
| Marker | What it measures | Reasonable target |
|---|---|---|
| ApoB | The number of atherogenic lipoprotein particles — a better risk marker than LDL-C | < 80 mg/dL for average risk; < 60 mg/dL if risk is elevated |
| Fasting insulin | Earliest detectable signal of insulin resistance, often abnormal for years before glucose | 2–6 µIU/mL |
| HbA1c | Three-month average glycemia; confirms whether insulin resistance has become glycemic | < 5.4% |
| hs-CRP | Systemic inflammation; elevated values track with cardiovascular and metabolic risk | < 1.0 mg/L |
| VO2 max (estimated) | Cardiorespiratory fitness — the highest-signal single number you can own | Above the 75th percentile for your age and sex |
A VO2 max estimate does not require a lab. A wearable with a reasonable algorithm, or a supervised twelve-minute run test, is enough to establish a baseline and detect change over a training block.
Optimization without measurement is guesswork
The word optimization implies a feedback loop: a measured state, an intervention, a re-measurement, and a decision. Remove the measurement and you are left with belief. Most people running a longevity routine cannot say what their ApoB was before they started, which means they cannot tell whether the routine did anything at all.
The loop is simple. Establish a baseline across the five markers. Change one thing at a time — training structure, protein intake, sleep timing, a lipid-lowering conversation with your physician. Give it eight to twelve weeks, long enough for HbA1c and ApoB to reflect the change. Retest. Keep what moved the number; drop what did not.
This is also the cheapest form of skepticism available. It costs a few hundred dollars a year to find out whether a supplement stack is working, which is considerably less than the stack. The people who make real progress over a decade are not the ones with the longest protocol — they are the ones with the longest series of measurements.
Run the full protocol
Training structure, nutrition, sleep and supplementation, laid out as a system with the evidence tier attached to each element.
Longevity ProtocolGet the biomarkers tested
A comparison of the lab-testing services that cover ApoB, fasting insulin, HbA1c and hs-CRP, with pricing and what each one is actually good for.
Lab testing comparisonFrequently asked questions
What does longevity optimization mean?
Longevity optimization is the deliberate management of the modifiable inputs — cardiorespiratory fitness, muscle mass, sleep, metabolic health, and blood lipids — that determine how long you stay functional, not simply how long you stay alive. In practice it means measuring a small set of biomarkers, changing training and nutrition against them, and re-measuring. It is closer to asset management than to medicine.
What are the most evidence-backed longevity interventions?
Four interventions carry the strongest human evidence: raising VO2 max, maintaining or building muscle through resistance training, protecting seven to nine hours of sleep, and keeping metabolic markers — fasting insulin, HbA1c, ApoB — in a healthy range. Observational and trial data for these dwarf the evidence base for rapamycin, senolytics, or NAD precursors in healthy humans.
What biomarkers should I track for longevity?
If you have never tested, start with five: ApoB for atherosclerotic risk, fasting insulin for early insulin resistance, HbA1c for three-month glycemic control, hs-CRP for systemic inflammation, and an estimated VO2 max for cardiorespiratory fitness. Those five cover the leading causes of both death and functional decline and can all be obtained cheaply.
Is longevity optimization worth it?
The high-evidence portion of it is unambiguously worth it: fitness, muscle, sleep and metabolic health improve how you feel this year as well as your risk curve over decades. The speculative portion — unproven compounds, expensive full-body scans, supplement stacks marketed on mouse data — has a much weaker return and frequently substitutes for the boring interventions that work.
What is the difference between lifespan and healthspan?
Lifespan is total years lived. Healthspan is the number of years lived without significant chronic disease or functional decline. In most developed countries the gap between the two is roughly a decade. Optimizing for healthspan means training and testing so the final years are compressed into a short decline rather than a long one.
Written by
John Stewart — Founder, Performance Protocol
John is an operator with two decades of experience building and leading performance-driven teams. He is not a physician. Performance Protocol exists because he needed a system for training, recovery, hormones, and cognitive output that was built on data rather than marketing — and could not find one.
Every protocol on this site references peer-reviewed research, with full citations listed on each page so claims can be verified at the source.
LinkedIn profile